Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 6:24 a.m.

    📋 FULCRUM THERAPEUTICS, INC. (FULC) - Clinical Trial Update

    Filing Date: 2022-06-10

    Accepted: 2022-06-10 16:15:59

    Event Type: Clinical Trial Update

    Event Details:

    Fulcrum Therapeutics (FULC) Announces Clinical Trial Update Fulcrum Therapeutics (FULC) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update.

    🔬 Clinical Development Pipeline (FULCRUM THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Losmapimod DRUG Phase PHASE2 Facioscapulohumeral Muscular Dystrophy (FSHD) ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Fulcrum Therapeutics
    • CIK: 0001680581
    • Ticker Symbol: FULC
    • Period End Date: 2022-06-10
    • Document Type: 8-K

Search

News categories